Runtex Group (002923.SZ) has obtained approval for the listing application of lanthanum carbonate chemical raw materials.

Wisdom Financial News APP News, Rundo Shares (002923.SZ) announced that the company recently received the "Notice of Approval for Marketing Authorization of Lanthanum Carbonate" issued by the National Medical Products Administration. Lanthanum carbonate chewable tablets are used for the treatment of hyperphosphatemia in chronic kidney failure patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. This approval expands the company's product portfolio in the field of chronic disease treatment, in line with the company's development strategy.